Department of Anatomy and Histology, Bangabandhu Sheikh Mujibur Rahman Agricultural University, Gazipur, Bangladesh.
Bio-ID Centre, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
Int Immunopharmacol. 2021 Aug;97:107686. doi: 10.1016/j.intimp.2021.107686. Epub 2021 Apr 17.
The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is having a disastrous impact on global health. Recently, several studies examined the potential of vitamin D to reduce the effects of SARS-CoV-2 infection by modulating the immune system. Indeed, vitamin D has been found to boost the innate immune system and stimulate the adaptive immune response against SARS-CoV-2 infection. In this review, we provide a comprehensive update of the immunological mechanisms underlying the positive effects of vitamin D in reducing SARS-CoV-2 infection as well as a thorough survey of the recent epidemiological studies and clinical trials that tested vitamin D as a potential therapeutic agent against COVID-19 infection. We believe that a better understanding of the histopathology and immunopathology of the disease as well as the mechanism of vitamin D effects on COVID-19 severity will ultimately pave the way for a more effective prevention and control of this global pandemic.
持续的严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)大流行对全球健康造成了灾难性的影响。最近,有几项研究探讨了维生素 D 通过调节免疫系统来降低 SARS-CoV-2 感染影响的潜力。事实上,已经发现维生素 D 可以增强先天免疫系统,并刺激针对 SARS-CoV-2 感染的适应性免疫反应。在这篇综述中,我们提供了维生素 D 在降低 SARS-CoV-2 感染方面的积极作用的免疫机制的全面更新,以及对最近测试维生素 D 作为 COVID-19 感染潜在治疗剂的流行病学研究和临床试验的彻底调查。我们相信,更好地了解疾病的组织病理学和免疫病理学以及维生素 D 对 COVID-19 严重程度的影响机制,最终将为更有效地预防和控制这一全球大流行铺平道路。